#biopharmaceutical

3 stories

#addex therapeutics #agilent #ai #atm offering #business #cash runway #clinical pipeline #companion diagnostics #digital pathology #funding #gabab #healthcare

Agilent Acquires Proscia for AI Pathology Expansion
Agilent buys Proscia for up to $270m to boost AI-powered digital pathology tools.
Pulse 2.0 · 1m
Addex Therapeutics Cash Runway at Risk
Addex Therapeutics' cash runway shrinks as it regains GABAB rights and faces funding pressure.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Ichor Biologics seeks $80-100M PE funding for minority stake
Hyderabad biotech firm aims to raise $80-100 million from private equity to expand plasma therapy operations
The Economic Times · 1m